Mutagenic and genotoxic activities of Phospholipase A2 Bothropstoxin-I from Bothrops jararacussu in Drosophila melanogaster and human cell lines

Int J Biol Macromol. 2021 Jul 1:182:1602-1610. doi: 10.1016/j.ijbiomac.2021.05.114. Epub 2021 May 24.

Abstract

Phospholipase A2 Bothropstoxin-I (PLA2 BthTX-I) is a myotoxic Lys49-PLA2 from Bothrops jararacussu snake venom. In order to evaluate the DNA damage caused by BthTX-I, we used the Somatic Mutation and Recombination Test (SMART) in Drosophila melanogaster and Comet assay in HUVEC and DU-145 cells. For SMART, different concentrations of BthTX-I (6.72 to 430 μg/mL) were used and no significant changes in the survival rate were observed. Significant frequency of mutant spots was observed for the ST cross at the highest concentration of BthTX-I due to recombinogenic activity. In the HB cross, BthTX-I increased the number of mutant spots at intermediate concentrations, being 53.75 μg/mL highly mutagenic and 107.5 μg/mL predominantly recombinogenic. The highest concentrations were neither mutagenic nor recombinogenic, which could indicate cytotoxicity in the wing cells of D. melanogaster. In vitro, all BthTX-I concentrations (1 to 50 μg/mL) induced decrease in HUVEC cell viability, as well as in DU-145 cells at concentrations of 10, 25, and 50 μg/mL. The comet assay showed that in HUVEC and DU-145 cells, all BthTX-I concentrations promoted increase of DNA damage. Further studies should be performed to elucidate the mechanism of action of PLA2 BthTX-I and its possible use in therapeutic strategies against cancer.

Keywords: Comet assay; Lys49-PLA(2); Myotoxin; SMART; Somatic mutation and recombination test.

MeSH terms

  • Animals
  • Bothrops / metabolism*
  • Cell Line
  • Cell Survival / drug effects
  • Comet Assay
  • Crotalid Venoms / toxicity*
  • Drosophila melanogaster
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Mutation / genetics
  • Phospholipases A2 / metabolism*

Substances

  • Crotalid Venoms
  • bothropstoxin
  • Phospholipases A2